The safety and efficacy of cisatracurium
β
T. Taivainen; G. H. Meakin; O. A. Meretoja; K. Wirtavuori; R. J. Perkins; A. K.
π
Article
π
2000
π
John Wiley and Sons
π
English
β 252 KB
We studied the neuromuscular and cardiovascular effects of a single, rapidly administered intravenous dose of cisatracurium 0.15 mg.kg(-1) in 27 infants (aged 1-23 months) and 24 children (aged 2-12.5 years). After midazolam premedication, anaesthesia was induced and maintained with thiopental and a